TCRXTScan Therapeutics Inc. Common Stock
0.7795USD+0.43%Mkt Cap: 50.94M $P/E: —3d ago
TScan Therapeutics, Inc., a clinical-stage biotechnology company, develops T cell receptor-engineered T cell (TCR-T) therapies for the treatment of patients with cancer in the United States. The company's lead product is…
Industry Peers
Biotechnology$138.82BUSDP/E 31.9
$85.87BUSDP/E 20.5
$61.34BUSDP/E 39.8
$65.05BUSDP/E 39.6
$57.94BUSD
$45.95BUSDP/E 19.6
$44.89BUSD
$42.36BUSDP/E 67.2
$35.43BUSDP/E 32.6
$31.61BUSDP/E 41.2
$29.28BUSD
$27.47BUSD
$26.22BUSD
$25.91BUSDP/E 16.2
$20.86BUSDP/E 26.3
$19.26BUSDP/E 26.6
$16.61BUSDP/E 19.6
$16.51BUSDP/E 17.4
$15.93BUSD
$13.40BUSDP/E 17.0
Key Statistics
Company
Market Cap50.94M $
Enterprise Value43.35M $
Revenue (TTM)7.11M $
Gross Profit-88.32M $
Net Income (TTM)-129.77M $
Revenue/Share0.1050 USD
Last Price0.7795 USD
Fiscal Year EndDec 2025
MR QuarterJun 2026
Employees138
CountryUS
SectorHealthcare
IndustryBiotechnology
ISIN—
Valuation
P/E (Trailing)—
P/E (Forward)-0.83
PEG—
EV/EBITDA-0.38
EV/Revenue6.10
P/S7.40
P/B0.48
EPS (TTM)-0.93
EPS (Forward)-0.94
52W Range
0.71603% of range2.570
52W High2.570 USD
52W Low0.7160 USD
Profitability
Gross Margin0.00%
Oper. Margin-2901.33%
EBITDA Margin0.00%
Profit Margin-1256.81%
ROE-105.40%
ROA-56.72%
Growth
Revenue Growth-65.80%
Earnings Growth—
Cash Flow & Leverage
Operating CF-135.32M $
CapEx (TTM)4.41M $
FCF Margin-1123.95%
FCF Yield-156.90%
Net Debt-9.26M $
Net Debt/EBITDA0.08
Balance Sheet
Debt/Equity0.76
Current Ratio3.37
Quick Ratio3.23
Book Value/Sh1.613 USD
Cash/Share1.478 USD
Dividends
Fwd Div Rate—
Trail. Div Rate0.0000 USD
Div. Yield—
5Y Avg Yield—
Payout Ratio0.00%
Ex-Div Date—
Pay Date—
Analyst Consensus
Rating1.5 (Buy)
Strong BuyBuyHoldSellStr. Sell
Target (Mean)6.000 USD
Upside (mean)+669.7%
Target Range5.000 USD – 7.000 USD
$5.000+669.7% to mean$7.000
# Analysts4
Ownership
Shares Out.61.07M
Float57.82M
Insiders0.19%
Institutions62.44%
Short Interest
Short Ratio1.8d
Short % Float3.48%
Short % Out.2.39%
Shares Short1.56M
Short (prev mo.)708.20K
Technical
SMA 500.8831 (-11.7%)
SMA 2001.026 (-24.0%)
Beta1.07
S&P 52W Chg18.16%
Avg Vol (30d)531.48K
Avg Vol (10d)359.62K
Technical Indicators
RSI (14)44.0
MACD-0.0329
MACD Signal-0.0417
MACD Hist.+0.0088
BB Upper0.8053 USD
BB Middle0.7666 USD
BB Lower0.7280 USD
BB Width10.08%
ATR (14)0.0522 USD
Vol Ratio (20d)0.27x